Sign In
Buy GILD
$125.16
+0.110 (+0.0880%)
At Close: Jun 24, 2026
Gilead's Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada® for HIV Prevention
08:51am, Thursday, 20'th Jun 2024
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced topline results from an interim analysis of its pivotal, Phase 3 PURPOSE 1 trial indicating that the company'
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
03:27pm, Monday, 17'th Jun 2024
Biotech stocks operate under a core ethos. While there's been much talk about financially viable sectors – from tech to cryptocurrencies to even precious metals – when you think about it, nothing
2 June Bargains With Up To 7.6% Yield
09:00am, Saturday, 15'th Jun 2024
There are always opportunities in this market for stocks despite high total market valuation. Gilead Sciences offers strong growth potential with a well-covered dividend yield of 4.8% and a promising
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
04:19pm, Friday, 14'th Jun 2024
Gilead stock jumped Friday after surprising Wall Street with preclinical test results for an under-the-radar weight-loss drug.
Gilead Stock Gains. It's Trying to Get Into the Obesity Drug Game.
02:27pm, Friday, 14'th Jun 2024
A success would be a gamechanger for the biotech company known for its HIV treatments.
New Kite Clinical Research and Real-World Evidence for Yescarta® Demonstrate Benefit From Earlier Lines of Treatment
03:00am, Friday, 14'th Jun 2024
SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced results from three new analyses for Yescarta® (axicabtagene ciloleucel) in relapsed/refractory (R/R) larg
Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
07:12pm, Thursday, 13'th Jun 2024
The latest trading day saw Gilead Sciences (GILD) settling at $63.56, representing a -1.21% change from its previous close.
Grant & Eisenhofer, Jenner Law, Burg Simpson, and The Lawrence Law Firm are jointly issuing the following public statement following Gilead's June 4th press release reported in the San Francisco Chron
Gilead Sciences, Inc. (GILD) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
09:00pm, Wednesday, 12'th Jun 2024
Gilead Sciences, Inc. (NASDAQ:GILD ) Goldman Sachs 45th Annual Global Healthcare Conference June 12, 2024 1:20 PM ET Company Participants Daniel O'Day - Chairman and Chief Executive Officer Conference
3 No-Brainer Nasdaq Stocks to Buy in June
01:01pm, Monday, 10'th Jun 2024
24/7 Insights The Nasdaq is up a stunning 14.5% this year after a massive 43% gain in 2023.
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
06:50am, Saturday, 08'th Jun 2024
Gilead Sciences is a safe, reliable dividend stock. Organon pays a high dividend yield and has been a big winner for investors this year.
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
10:06am, Thursday, 06'th Jun 2024
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced data from the Phase 2b MYR204 open-label study assessing the efficacy and safety of the first-in-class entry
Gilead Sciences, Inc. (GILD) Jefferies 2024 Global Healthcare Conference
02:05pm, Wednesday, 05'th Jun 2024
Gilead Sciences, Inc. (NASDAQ:GILD ) Jefferies 2024 Global Healthcare Conference June 5, 2024 11:00 AM ET Company Participants Merdad Parsey - Chief Medical Officer Conference Call Participants Michae
Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100?
09:45am, Wednesday, 05'th Jun 2024
Walgreens has lost some 70% of its value, and the stock now yields 6.5%. Kraft Heinz has experienced a similar slump, and its shares offer a 4.6% yield.
